TetraGraph receives regulatory approval and additional order from South Korea
Press release: Uppsala, July 8, 2019. Senzime AB (publ) today announces that TetraGraph has been approved in Korea and that the local distributor has followed up the order in May with an additional order comprising 30 TetraGraph systems. This second order is part of the contracted sales volume of the South Korean market. There are more than 3,000 hospitals in South Korea and more than 1.3 million operations are performed annually of which muscle relaxants are used in more than half of them. Senzime's marketing team recently conducted a TetraGraph training for over 80 salespeople